How did Chemours (cc) perform in the latest trading session?
In the latest trading session, Chemours (CC) closed at $35.54, marking a -0.25% move from the previous day. This change was narrower than the S&P 500's daily loss of 0.97%. At the same time, the Dow lost 0.96%, and the tech-heavy Nasdaq gained 0.23%.
Can Chemours (cc) run higher on strong earnings estimate revisions?
For Chemours, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CC going forward to see if this recent jump can turn into more strength down the road.
Why did Chemours'sales slow in Q4?
To be fair, however, there are other moving parts in the picture. For example, sales in Chemours' titanium division (accounting for 55% of fourth-quarter sales) slowed down in the quarter because of issues in the auto sector.
What does Chemours Company do?
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts, Chemical Solutions, and Corporate and Other.
See more
Is Chemours a good stock?
Chemours currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
What happened Chemours?
What happened. Shares of Chemours (CC 1.90%), a specialty chemical company, fell sharply at the open of trading on Friday, losing as much as 14.5% of their value in the first few minutes of trading. The big story was the company's earnings release, which hit the market after the close on Thursday.
Is Chemours a publicly traded company?
Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.
Is CCS a good buy?
CCS is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 3.51 right now. For comparison, its industry sports an average P/E of 5.24. Over the last 12 months, CCS's Forward P/E has been as high as 8.62 and as low as 3.27, with a median of 4.92.
Are DuPont and Chemours the same company?
DuPont filed its initial Form 10 with the SEC in December 2014 and announced that the new company would be called "The Chemours Company". The spin-off to DuPont shareholders was completed on July 1, 2015, and Chemours' stock began trading on the New York Stock Exchange on the same date.
How much did Tennant get from DuPont?
In a follow-up case in 2017, he won a $671 million settlement on behalf of more than 3,500 plaintiffs in personal-injury claims against DuPont. And here's where the story could end, the hero with his fist aloft.
Who bought Chemours?
DraslovkaDraslovka, a multi-family-owned Czech speciality chemicals firm, has agreed to acquire the Mining Solutions business of Chemours for $520 million, or 10 x EBITDA in 2020. This came shortly after its agreement to buy Sasol's sodium cyanide business $101.7 million.
When did DuPont split of Chemours?
2015'Unlimited' Liabilities Chemours spun off from E.I. DuPont & Co. in 2015 and took on environmental liabilities generated by the chemical maker.
When did DuPont spin-off Chemours?
1 July 2015DuPont has completed the separation of its Performance Chemicals segment through the spin-off of The Chemours Company as an independent, publicly traded corporation on 1 July 2015. From that date, Chemours began 'regular way' trading on the New York Stock Exchange under the symbol 'CC'.
Latest Stocks Videos
Zacks
In The Money: Groundhog Day: Mega-Cap Tech Stocks Out From the Shadows? Feb 02, 2022
Latest Stocks Videos
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank.
Zacks
In The Money: Groundhog Day: Mega-Cap Tech Stocks Out From the Shadows? Feb 02, 2022
What happened
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank.
So what
Shares of specialty chemical company Chemours ( CC -4.99% ) jumped nearly 14% as trading opened for the day. Although they quickly settled down to a mid-single-digit gain by 10 a.m. EDT, the quick jump was clearly a reaction to the company's earnings, which were released after the close yesterday.
Now what
Chemours' top line fell slightly, going from $1.4 billion in the first quarter of 2019 to $1.3 billion in the same period of 2020. Although the company's titanium coatings business did well (sales were up 10% in the segment), its other two divisions (fluoroproducts and chemical solutions) saw year-over-year sales declines.